Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target
Carlos Cuesta‐Mateos, Fernando Terrón, Marco Herling
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15

Showing 15 citing articles:

ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
Shiyong Xin, Xiang Liu, Ziyao Li, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
CCL21/CCR7 axis as a therapeutic target for autoimmune diseases
Le Han, Lingling Zhang
International Immunopharmacology (2023) Vol. 121, pp. 110431-110431
Closed Access | Times Cited: 19
A novel anti-mouse CCR7 monoclonal antibody, C7Mab-7, demonstrates high sensitivity in flow cytometry, western blot, and immunohistochemistry
Hiroyuki Satofuka, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101948-101948
Open Access
Brief research report: in-depth immunophenotyping reveals stability of CD19 CAR T-cells over time
Ivan Odak, Lâle M. Bayir, Lennart Riemann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I
Nyam‐Osor Chimge, Min-Hsuan Chen, Cu Nguyen, et al.
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 7
Differential Response of Mycosis Fungoides Cells to Vorinostat
Zachary A. Bordeaux, Sriya V. Reddy, Kevin K. Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8075-8075
Open Access | Times Cited: 5
Proliferating CLL cells express high levels of CXCR4 and CD5
Daniel Friedman, Drshika P. Mehtani, Jennifer Vidler, et al.
HemaSphere (2024) Vol. 8, Iss. 12
Open Access | Times Cited: 1
Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options
Yifan Zhao, Ruiting Guo, Xinping Cao, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110396-110396
Closed Access | Times Cited: 3
Pareto task inference analysis reveals cellular trade-offs in diffuse large B-Cell lymphoma transcriptomic data
Jonatan Blais, Julie Jeukens
Frontiers in Systems Biology (2024) Vol. 4
Open Access
Targeted small molecule therapy and inhibitors for lymphoma
Zhonghui Wang, Xiang Zheng, Guo‐Wu Rao, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 14, pp. 1465-1484
Closed Access
Deciphering avian hematopoietic stem cells by surface marker screening and gene expression profiling
Neslihan Meriç, Pınar Çolakoğlu Erkan, Fatih Kocabaş
Molecular Immunology (2024) Vol. 175, pp. 20-30
Closed Access
Mapping integral cell-type-specific interferon-induced gene regulatory networks (GRNs) involved in systemic lupus erythematosus using systems and computational analysis
Blessy Kiruba, Akshayata Naidu, Vino Sundararajan, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41342-e41342
Open Access
Exploring G Protein-Coupled Receptors in Hematological Cancers
C. Tsang, Paweł Kozielewicz
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4000-4009
Closed Access
Can the Pareto optimality theory reveal cellular trade-offs in diffuse large B-Cell lymphoma transcriptomic data?
Jonatan Blais, Julie Jeukens
Research Square (Research Square) (2023)
Open Access
Splice Variants of G Protein-Coupled Receptors Expressed in Cancers: Effective Targeting with Monoclonal Antibodies and Antibody-Like Scaffolds As Ligands Irrespective of the Pharmacological Status of Isoforms
Peter J. Wookey, Pragya Gupta, David L. Hare, et al.
Springer eBooks (2022), pp. 1-45
Closed Access
Page 1

Scroll to top